参考文献/References:
[1] Napodano M, Pasquetto G, Sacc S, et al. Intracoronary thrombectomy improves myocardial reperfusion in patients undergoing direct angioplasty for acute myocardial infarction[J]. J Am Coll Cardiol, 2003, 42: 1395 - 1402.
[2] Svilaas T, Vlaar PJ, Van der Horst IC, et al. Thrombus aspiration during primary percutaneous coronary intervention[J]. N Engl J Med, 2008, 358: 557 - 567.
[3] Stone GW, Webb J, Cox DA, et al. Distal microcirculatory protection during percutaneous coronary intervention in acute ST-segment elevation myocardial infarction: a randomized controlled trial[J]. JAMA, 2005, 293: 1063 - 1072.
[4] Danzi GB, Capuano C, Sesana M, et al. Variability in extent of platelet function inhibition after administration of optimal dose of glycoprotein Ⅱb/Ⅲa receptor blockers in patients undergoing a high-risk percutaneous coronary intervention[J]. Am J Cardiol, 2006, 97: 489 - 493.
[5] Yang TY, Chang ST, Chung CM, et al.Restoration of normal coronary flow with tirofiban by intracoronary administration for no-reflow phenomenon after stent deployment[J]. Int Heart J, 2005, 46: 139 - 145.
[6] 杨新春, 张大鹏, 王乐丰, 等. 冠状动脉内应用国产替罗非班对急性ST段抬高心肌梗死急诊介入治疗后心肌灌注和临床预后的影响[J]. 中华心血管病杂志, 2007, 35: 517 - 522.
[7] de Lemos JA, Antman EM, Gibson CM, et al. Abciximab improves both epicardial flow and myocardial reperfusion in ST-elevation myocardial infarction. Observations from the TIMI 14 trial[J]. Circulation, 2000, 101: 239 - 243.
[8] Topol EJ. GUSTO V Investigators. Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: the GUSTO V randomised trial[J]. Lancet, 2001, 357: 1905 - 1914.
[9] Herrmann HC, Moliterno DJ, Ohman EM, et al. Facilitation of early percutaneous coronary intervention after reteplase with or without abciximab in acute myocardial infarction: results from the SPEED (GUSTO-4 Pilot) Trial[J]. J Am Coll Cardiol, 2000, 36: 1489 - 1496.
[10] Kleiman NS, Ohman EM, Califf RM, et al. Profound inhibition of platelet aggregation with monoclonal antibody 7E3 Fab after thrombolytic therapy. Results of the Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) 8 Pilot Study[J]. J Am Coll Cardiol, 1993, 22: 381 - 389.
[11] Brener SJ, Zeymer U, Adgey AA, et al. Eptifibatide and low-dose tissue plasminogen activator in acute myocardial infarction: the integrilin and low-dose thrombolysis in acute myocardial infarction (INTRO AMI) trial[J]. J Am Coll Cardiol, 2002, 39: 377 - 386.
[12] Giugliano RP, Roe MT, Harrington RA, et al. Combination reperfusion therapy with eptifibatide and reduced-dose tenecteplase for ST-elevation myocardial infarction:results of the integrilin and tenecteplase in acute myocardial infarction (INTEGRITI) Phase II Angiographic Trial[J]. J Am Coll Cardiol, 2003, 41: 1251 - 1260.
[13] Martínez-Ríos MA, Rosas M, González H, et al. Comparison of reperfusion regimens with or without tirofiban in ST-elevation acute myocardial infarction[J]. Am J Cardiol, 2004, 93: 280 - 287.
相似文献/References:
[1]齐 立,李慎茂,俸军林,等. 动脉溶栓与机械碎栓联合动脉溶栓的对比分析[J].介入放射学杂志,2012,(03):180.
,,et al. Ｃｏｍｐａｒｉｓｏｎ ｏｆ ｔｈｅ ｔｈｅｒａｐｅｕｔｉｃ ｅｆｆｉｃａｃｙ ｂｅｔｗｅｅｎ ｓｉｍｐｌｅ ａｒｔｅｒｉａｌ ｔｈｒｏｍｂｏｌｙｓｉｓ ａｎｄ ｍｅｃｈａｎｉｃａｌ ｔｈｒｏｍｂｅｃｔｏｍｙ ｃｏｍｂｉｎｅｄ ｗｉｔｈ ａｒｔｅｒｉａｌ ｔｈｒｏｍｂｏｌｙｓｉｓ ｆｏｒ ａｃｕｔｅ ｃｅｒｅｂｒａｌ ｉｎｆａｒｃｔｉｏｎ ａｔ ｉｔｓ ｕｌｔｒａｅａｒｌｙ ｓｔａｇｅ[J].journal interventional radiology,2012,(10):180.
[2]刘顶成,杨学良.介入溶栓治疗双下肢动脉血栓一例[J].介入放射学杂志,2000,(03):173.
[3]姚绍鑫,曹亦宾,张卫涛,等.超早期脑梗死的动脉内接触性溶栓[J].介入放射学杂志,2000,(03):141.
[4]池宝成,程悦好,王亚军,等.尿激酶阴茎海绵体冲洗治疗阴茎海绵体血栓形成一例[J].介入放射学杂志,1997,(02):126.
[5]李国均,祖茂衡,徐浩,等.经患侧足背静脉推注尿激酶治疗下肢深静脉血栓形成[J].介入放射学杂志,1997,(03):128.
[6]蒋晓东,周胜利,刘希胜,等.动脉内联合灌注尿激酶、丹参及肝素的溶栓效果观察[J].介入放射学杂志,1997,(04):208.
[7]高文洁,李霞.介入治疗中出现神经症状一例[J].介入放射学杂志,1998,(04):206.
[8]高文洁,李霞.介入治疗中出现神经症状一例[J].介入放射学杂志,1999,(01):33.
[9]陆永,季博青,尚克中,等.腹部大血管多发性栓塞经导管尿激酶溶栓治疗一例[J].介入放射学杂志,1992,(01):56.
[10]蒋远东,唐玉新,张弘,等.导管溶栓治疗下肢动脉栓塞(附9例报告)[J].介入放射学杂志,1993,(01):49.